Sign in

Shigeru Sakato

Research Analyst at JPMorgan Chase & Co.

Shigeru Sakato is an equity research analyst at JPMorgan Chase & Co., covering industrial and materials companies with a particular focus on sectors such as chemicals and specialty materials. He has provided key analysis on companies like DuPont de Nemours, contributing thoughtful questions and insights during earnings calls, which demonstrate his familiarity and influence within the industrials research space. Although specific quantitative performance metrics, such as TipRanks rankings or investment return statistics, are not publicly available, his regular appearances in industry earnings discussions and representation of JPMorgan on analyst calls suggest a solid reputation and continued trust from his firm. Details about his exact career start date, previous employers, and regulatory credentials such as FINRA registrations or securities licenses could not be verified from currently available public sources.

Shigeru Sakato's questions to DuPont de Nemours (DD) leadership

Question · Q3 2025

Shigeru Sakato followed up on the 80/20 initiatives discussed at Investor Day, specifically asking about opportunities to prune the portfolio on the edges and the company's strategy for morphing the portfolio towards more secular-based end markets.

Answer

Lori Koch, CEO, mentioned Beth Ferreira's deployment of the 80/20 framework in diversified industrials to improve margins. She also stated the goal to shift the portfolio from 50/50 (healthcare/water vs. diversified) to two-thirds/one-third in favor of secular-based, mid-single-digit growth markets, without specifying which businesses would be pruned.

Ask follow-up questions

Question · Q3 2025

Shigeru Sakato followed up on the 80/20 initiatives discussed at Investor Day and inquired about opportunities to prune the portfolio on the edges.

Answer

CEO Lori Koch noted the active deployment of the 80/20 toolkit across diversified industrials to improve margins. She also mentioned the goal to morph the portfolio towards more secular-based end markets, aiming for a 2/3 healthcare and water to 1/3 diversified businesses mix, without specifying particular divestitures.

Ask follow-up questions

Best AI for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%